Tactile Medical to Release Fourth Quarter and Fiscal Year 2025 Financial Results on February 17, 2026
Tactile Medical (Nasdaq: TCMD) will release fourth quarter and fiscal year 2025 financial results after the market closes on February 17, 2026.
Rhea-AI Summary
Tactile Medical (Nasdaq: TCMD) will release fourth quarter and fiscal year 2025 financial results after the market closes on February 17, 2026. Management will host a conference call and Q&A at 5:00 p.m. ET the same day.
Dial-in details: 877-407-3088 (international 201-389-0927), access code 13758303. A live webcast and archived replay will be available at investors.tactilemedical.com and a phone replay for two weeks.
About Tactile Medical: the company develops at-home therapies for chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease.
Positive
- None.
Negative
- None.
Details
News Market Reaction – TCMD
On Feb 4, the first trading day after this news, TCMD closed 2.09% below the previous close.
Data tracked by StockTitan Argus for the Feb 4 session.
Key Figures
- Current price
- $28.73
- Prior to Q4/FY25 earnings-date announcement
- 52-week range
- $8.6098–$31.38
- 52-week low and high levels
- Market cap
- $644,604,897
- Equity value before Q4/FY25 earnings release
- Earnings release date
- February 17, 2026
- Q4 and fiscal year 2025 results after market close
- Conference call time
- 5:00 p.m. Eastern Time
- Management call to discuss Q4 and FY25 results
- Domestic dial-in
- 877-407-3088
- US access number for earnings conference call
- International dial-in
- 201-389-0927
- International access number for earnings conference call
- Access code
- 13758303
- Code for live call and replay access
Historical Context
-
Announcement of participation and fireside chat at a healthcare conference.
-
Q3 2025 beat with 17% revenue growth and raised full-year guidance.
-
Six‑month trial data showing sustained benefits of Flexitouch Plus therapy.
-
Announcement of Q3 2025 earnings release timing and access details.
-
Q2 2025 revenue growth, solid margins, and updated 2025 guidance.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MINNEAPOLIS, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that fourth quarter and fiscal year 2025 financial results will be released after the market closes on Tuesday, February 17, 2026.
Management will host a conference call with a question and answer session at 5:00 p.m. Eastern Time on February 17, 2026, to discuss the results of the quarter and fiscal year. Those who would like to participate may dial 877-407-3088 (201-389-0927 for international callers) and provide access code 13758303. A live webcast of the call will also be provided on the investor relations section of the Company's website at investors.tactilemedical.com.
For those unable to participate, a replay of the call will be available for two weeks at 877-660-6853 (201-612-7415 for international callers); access code 13758303. The webcast will be archived at investors.tactilemedical.com.
About Tactile Systems Technology, Inc. (DBA Tactile Medical)
Tactile Medical is a leader in developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease by helping them live better and care for themselves at home. Tactile Medical collaborates with clinicians to expand clinical evidence, raise awareness, increase access to care, reduce overall healthcare costs and improve the quality of life for tens of thousands of patients each year.
Investor Inquiries:
Sam Bentzinger
Gilmartin Group
investorrelations@tactilemedical.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.